Bob, you are right of course, but it is hard to really see SOL as a diversified investment house with a history of 'steady as she goes', suddenly take on the qualities that drove CSL as a highly focused leading niche operator in the market of plasma and blood products.
How much higher can we go?, page-91
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SOL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$34.98 |
Change
0.310(0.89%) |
Mkt cap ! $12.41B | |||
| Open | High | Low | Value | Volume |
| $34.87 | $35.45 | $34.86 | $17.38M | 495.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 919 | $34.94 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $34.98 | 280 | 1 |
View Market Depth
| Last trade - 16.10pm 28/11/2024 (20 minute delay) ? |
| SOL (ASX) Chart |
